This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
External Beam Radiation Therapy in Combination With Talquetamab for the Treatment of Multiple Myeloma Patients With Extramedullary Disease | MicrobiomeTrials
← Back to trials NCT06572605
External Beam Radiation Therapy in Combination With Talquetamab for the Treatment of Multiple Myeloma Patients With Extramedullary Disease SUSPENDED PHASE1, PHASE2 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2025-08-29Est. Completion: 2030-01-18
Enrollment target: 20 participantsLocations City of Hope Medical Center, Duarte, California, United States Other microbiome trials you might be interested in Multiple Myeloma (MM)
This is a prospective, single-arm, exploratory Phase II clinical study evaluating the efficacy and safety of HP-001 caps…
Tianjin, China Est. completion Dec 31, 2027
Multiple Myeloma
The purpose of this study is to evaluate the efficacy and safety of SVRd in NDMM patients presenting with extramedullary…
Changzhou, China Completed Aug 30, 2026